The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 230.50
Bid: 228.50
Ask: 231.00
Change: 21.50 (10.29%)
Spread: 2.50 (1.094%)
Open: 209.00
High: 233.00
Low: 209.00
Prev. Close: 209.00
FDEV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed PCA Dealing

26 Nov 2019 16:59

RNS Number : 7546U
Frontier Developments PLC
26 November 2019
 

26 November 2019

Not for publication, distribution or release, directly or indirectly, in whole or in part, in or into the United States, Australia, Canada, Japan or Republic of South Africa or any other jurisdiction in which such release, publication or distribution would be unlawful.

Please see the Important Notice at the end of this announcement.

Frontier Developments plc

("Frontier" or the "Company")

Proposed PCA Dealing

Frontier Developments plc (AIM: FDEV) today announces that it has been notified by Wendy Irvin-Braben (the "Selling Shareholder") of her intention to sell up to 1,250,000 ordinary shares of 0.5 pence each in the Company ("Sale Shares"), in response to investor demand, at a price of 1,200 pence per Sale Share (the "Sale"). The Selling Shareholder is the wife of, and therefore a person closely associated with, the chief executive officer of the Company, David Braben.

The Sale Shares represent approximately 3.2% of the Company's issued share capital. Assuming all the Sale Shares are sold, the Selling Shareholder will, following completion of the Sale, continue to hold 1.9% of the issued share capital of the Company. Therefore, including Wendy Irvin-Braben's residual shareholding, David Braben will have a total interest of 12,899,953 ordinary shares or 33.2% of the issued share capital of the Company following the Sale.

The Selling Shareholder and David Braben have undertaken that, without the prior written consent of Jefferies International Limited and Liberum Capital Limited, they will not dispose of any further Ordinary Shares for a period of 360 days after completion of the Sale (subject to customary exceptions).

The Company is not a party to the Sale and will not receive any proceeds from the Sale.

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation (EU) 596/2014. The person responsible for making this announcement on behalf of the Company is Alex Bevis.

Enquiries:

 

Frontier Developments +44 (0)1223 394 300

David Braben, CEO

Alex Bevis, CFO

Liberum - Nomad and Joint Broker +44 (0)20 3100 2000

Neil Patel / Cameron Duncan

Jefferies - Joint Broker +44 (0)20 7029 8000

Max Jones / William Brown

Tulchan Communications +44 (0)20 7353 4200

Matt Low / Deborah Roney / James Macey White 

 

About Frontier Developments plc

Frontier is a leading independent creator of self-published videogame franchises founded in 1994 by David Braben, co-author of the iconic Elite game. Based in Cambridge, Frontier uses its proprietary 'COBRA' game development technology to create innovative games, currently focusing on videogame consoles and personal computers.

Frontier's LEI number: 213800B9LGPWUAZ9GX18.

www.frontier.co.uk 

IMPORTANT NOTICE

In connection with the Sale, Jefferies International Limited ("Jefferies") and Liberum Capital Limited ("Liberum" and, together with Jefferies, the "Managers") or any of their respective affiliates may take up a portion of the Sale Shares as a principal position and in that capacity may retain, purchase, sell, offer to sell for its own accounts such Sale Shares and other securities of Frontier Developments plc or related investments in connection with the Sale or otherwise. Accordingly, references to the Sale Shares being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by either of the Managers and any of their respective affiliates acting as investors for their own accounts. The Managers do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

Jefferies and Liberum are each authorised and regulated by the FCA. Each of the Managers is acting for the Seller only in connection with the Sale and no one else, and will not be responsible to anyone other than the Seller for providing the protections offered to clients of the Managers nor for providing advice in relation to the Sale Shares or the Sale, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

This announcement has been issued by the Company on behalf of the Seller and is the sole responsibility of the Seller apart from the responsibilities and liabilities, if any, that may be imposed on Jefferies or Liberum by the Financial Services and Markets Act 2000. Neither Jefferies nor Liberum accepts any responsibility whatsoever and makes no representation or warranty, express or implied, for the contents of this announcement, including its accuracy, completeness or verification or for any other statement made or purported to be made by the Seller or on the Seller's behalf or on Jefferies' or Liberum's behalf, in connection with the Seller or the Sale, and nothing in this announcement is or shall be relied upon as a promise or representation in this respect, whether as to the past or the future. Each of Jefferies and Liberum accordingly disclaims to the fullest extent permitted by law all and any responsibility and liability, whether arising in tort, contract or otherwise, which it might otherwise have in respect of this announcement and any such statement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBLBDBRUDBGCL
Date   Source Headline
15th Aug 20177:05 amRNSPlanet Coaster passes 1 million units
15th Aug 20177:00 amRNSAppointment of Nomad and Joint Broker
4th Aug 20173:27 pmRNSNotification of Major Interest in Shares
28th Jul 201711:07 amRNSSecond Price Monitoring Extn
28th Jul 201711:01 amRNSPrice Monitoring Extension
28th Jul 20177:00 amRNSStrategic Investment
14th Jul 201711:31 amRNSBlock listing
23rd Jun 201711:08 amRNSEBT Dealings
22nd Jun 20177:00 amRNSPre-close Trading Update
2nd Jun 20173:42 pmRNSEBT & PDMR Dealings
1st Jun 20178:45 amRNSExecutive Director Option Awards
23rd May 20178:58 amRNSPCA Dealings
18th May 20172:00 pmRNSPCA Dealings
16th May 20177:00 amRNSElite Dangerous PlayStation 4 launch: 27 June 2017
12th May 20174:30 pmRNSPCA Dealings
11th May 20174:10 pmRNSDirector Dealings
9th May 20174:23 pmRNSNotification of Major Interest in Shares
8th May 20174:04 pmRNSDirector Dealings
3rd May 20174:25 pmRNSDirector Dealings
3rd May 20179:06 amRNSEBT Dealings
28th Apr 20174:26 pmRNSDirector Dealings
26th Apr 20174:21 pmRNSDirector, PDMR & PCA Dealings
26th Apr 20177:00 amRNSNotification of Major Interest in Shares
19th Apr 20179:05 amRNSSecond Price Monitoring Extn
19th Apr 20179:02 amRNSPrice Monitoring Extension
19th Apr 20177:00 amRNSTrading Update
7th Apr 20179:42 amRNSPCA Dealings
3rd Apr 20172:03 pmRNSBoard Appointment and Director Dealings
27th Mar 201711:32 amRNSPDMR Dealings
10th Mar 20173:45 pmRNSPCA Dealings
7th Mar 20179:26 amRNSNon-Executive Director Grant of Options
13th Feb 20173:38 pmRNSEBT Dealings
13th Feb 20173:37 pmRNSPDMR & Director Dealings
9th Feb 20177:00 amRNSInterim Results
6th Feb 20177:00 amRNSAnnounces Movie IP License for Third Franchise
19th Jan 20177:00 amRNSNotice of Results
16th Jan 20177:00 amRNSTrading Update
9th Jan 201710:19 amRNSBlock listing Interim Review
12th Dec 20169:02 amRNSDirector Dealing
9th Dec 20162:07 pmRNSEBT and Director Dealings
9th Dec 20167:00 amRNSElite Dangerous coming to Playstation 4 in 2017
18th Nov 20167:00 amRNSPlanet Coaster Release
15th Nov 20164:24 pmRNSPCA Dealings
24th Oct 201612:45 pmRNSEBT Dealings
21st Oct 20167:00 amRNSAppointment of a Chief Financial Officer
18th Oct 20163:21 pmRNSResult of AGM
17th Oct 20167:00 amRNSDirector/PDMR Grant of Options
19th Sep 20167:00 amRNSPosting of Annual Report and Notice of AGM
14th Sep 20169:16 amRNSExercise of Warrants and Total Voting Rights
9th Sep 20163:58 pmRNSDirector Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.